Drug(薬物リスト) DrugBank | All Description Patterns💬 Info on mouse-over

160 / 17,542 descriptions

No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes
指定難病告示番号
1 13 valent conjugated pneumococcal vaccine - - - - 1件: 265 💬
2 150 mg gsk1265744b - - - - 1件: 265 💬
3 300mg gemcabene Gemcabene - - - 1件: 265 💬
4 3tc - - - - 1件: 265 💬
5 600mg gemcabene Gemcabene - - - 1件: 265 💬
6 [n-trans-3-hexenoyl] human growth hormone releasing factor (1-44) acetate Acetate 1件: D02691 💬 1件: GHR 💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 1件: 265 💬
7 Abacavir Abacavir 2件: D00891, D07057 💬 - - 3件: 135, 265, 325 💬
8 Abacavir 300mg twice daily Abacavir 2件: D00891, D07057 💬 - - 1件: 265 💬
9 Abacavir sulfate Abacavir 2件: D00891, D07057 💬 - - 1件: 265 💬
10 Abacavir sulfate, lamivudine and zidovudine Abacavir 4件: D00353, D00413, D00891, D07057 💬 - - 1件: 265 💬
11 Abc - - - - 1件: 265 💬
12 Acetate Acetate - - - 43件:  1 ,  2 ,  6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬
13 Acetyl- l- carnitine Levocarnitine 3件: D02030, D02176, D04713 💬 - - 1件: 265 💬
14 Acetylcarnitine Acetylcarnitine - - - 2件:  2 , 265 💬
15 Acipimox Acipimox 1件: D07190 💬 - - 2件: 78, 265 💬
16 Akcea-angptl3-lrx - - - - 2件: 79, 265 💬
17 Amprenavir Amprenavir 1件: D00894 💬 - - 1件: 265 💬
18 Antiretroviral/anti hiv - - - - 1件: 265 💬
19 Aramchol Aramchol - - - 1件: 265 💬
20 Atazanavir Atazanavir 2件: D01276, D07471 💬 - - 1件: 265 💬
21 Atazanavir (atv) + ritonavir (rtv), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (nrtis) Atazanavir 3件: D00427, D01276, D07471 💬 - - 1件: 265 💬
22 Atazanavir (reyataz) Atazanavir 2件: D01276, D07471 💬 - - 1件: 265 💬
23 Atazanavir/ritonavir Atazanavir 3件: D00427, D01276, D07471 💬 - - 1件: 265 💬
24 Atorvastatin Atorvastatin 3件: D00258, D00887, D07474 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬
25 Atorvastatin calcium Atorvastatin 3件: D00258, D00887, D07474 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 1件: 265 💬
26 Atv - - - - 1件: 265 💬
27 Avandia administration for 6-12 weeks - - - - 1件: 265 💬
28 Azt - - - - 2件: 94, 265 💬
29 Azt/3tc - - - - 1件: 265 💬
30 Baricitinib Baricitinib 1件: D10308 💬 2件: JAK1, JAK2 💬 33件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 9件: 41, 46, 49, 50, 93, 107, 265, 268, 325 💬
31 Behavioral: 60-minutes of steady state exercise - - - - 1件: 265 💬
32 Behavioral: diet - - - - 1件: 265 💬
33 Behavioral: exercise - - - - 3件:  6 , 265, 299 💬
34 Behavioral: exercise training - - - - 1件: 265 💬
35 Bms-232632 - - - - 1件: 265 💬
36 Caffeine Caffeine 2件: D00528, D01453 💬 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 9件:  2 ,  6 , 13, 21, 46, 78, 96, 97, 265 💬
37 Calcium Calcium - - - 27件:  6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬
38 Carnitine Levocarnitine 3件: D02030, D02176, D04713 💬 - - 8件:  5 , 13, 58, 96, 97, 265, 298, 316 💬
39 Cd - - - - 6件:  6 , 46, 51, 96, 97, 265 💬
40 Cd-4 guided therapy interruption - - - - 1件: 265 💬
41 Cholic acid Cholic Acid 1件: D10699 💬 1件: NR1H4 💬 1件: Bile secretion 4件: 20, 234, 265, 310 💬
42 Cofactor - - - - 3件:  6 , 265, 288 💬
43 Cofactor supplementation (thiamine, riboflavin, l-carnitine) Levocarnitine 7件: D00050, D01622, D01913, D02030, D02176, D04713, D08580 💬 - - 1件: 265 💬
44 Combivir - - - - 1件: 265 💬
45 Combivir (zidovudine [azt] / lamivudine [3tc]) Lamivudine 2件: D00353, D00413 💬 - - 1件: 265 💬
46 Continuation of current haart (boosted protease inhibitor [pi] combination + 2 nrtis) - - - - 1件: 265 💬
47 Cyclophosphamide Cyclophosphamide 2件: D00287, D07760 💬 - - 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬
48 Device: poly-l-lactic acid L-Lactic acid 1件: D00111 💬 - - 1件: 265 💬
49 Device: venus versa - - - - 1件: 265 💬
50 Didanosine Didanosine 1件: D00296 💬 - - 2件: 25, 265 💬
51 Different haart regimens - - - - 1件: 265 💬
52 Diosmin Diosmin 1件: D07858 💬 - - 1件: 265 💬
53 Diosminex, 500 mg, tabletki powlekane - - - - 1件: 265 💬
54 Dolutegravir Dolutegravir 1件: D10066 💬 - - 2件:  2 , 265 💬
55 Dolutegravir 50 mg Dolutegravir 1件: D10066 💬 - - 1件: 265 💬
56 Efavirenz Efavirenz 1件: D00896 💬 - - 1件: 265 💬
57 Efavirenz (efv) Efavirenz 1件: D00896 💬 - - 1件: 265 💬
58 Emtricitabine Emtricitabine 1件: D01199 💬 - - 4件: 25, 93, 265, 325 💬
59 Emtricitabine/tenofovir Emtricitabine 2件: D01199, D06074 💬 - - 1件: 265 💬
60 Enfuvirtide Enfuvirtide 1件: D02499 💬 - - 2件: 25, 265 💬
61 Enfuvirtide (t20) Enfuvirtide 1件: D02499 💬 - - 1件: 265 💬
62 Fenofibrate Fenofibrate 1件: D00565 💬 1件: PPARA 💬 8件: Adipocytokine signaling pathway, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 5件:  8 , 79, 93, 94, 265 💬
63 Gemcabene Gemcabene - - - 2件: 79, 265 💬
64 Genetic: amplification by pcr and direct sequencing on the entire coding sequence and intron-exons boundaries of the candidate gene - - - - 1件: 265 💬
65 Genotropin (human recombinant growth hormone) Somatotropin 1件: D02691 💬 1件: GHR 💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 1件: 265 💬
66 Glycerine Glycerin 1件: D00028 💬 - - 1件: 265 💬
67 Growth hormone Somatotropin 1件: D02691 💬 1件: GHR 💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 12件:  2 , 13, 19, 46, 78, 96, 187, 191, 193, 195, 265, 299 💬
68 Growth hormone releasing hormone Somatotropin 1件: D02691 💬 1件: GHR 💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 1件: 265 💬
69 Gsk1265744b (sodium salt) containing 14c-gsk1265744b - - - - 1件: 265 💬
70 High-carbohdyrate breakfast - - - - 1件: 265 💬
71 High-dose regn4461 - - - - 1件: 265 💬
72 Hu leptin (a-100) Leptin - - - 1件: 265 💬
73 Human growth hormone Somatotropin 1件: D02691 💬 1件: GHR 💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 4件: 78, 187, 193, 265 💬
74 Human recombinant leptin (metreleptin) Leptin 1件: D05014 💬 1件: LEPR 💬 6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 1件: 265 💬
75 Indinavir Indinavir 3件: D00897, D02861, D03833 💬 - - 1件: 265 💬
76 Isis 304801 - - - - 1件: 265 💬
77 Kaletra (lopinavir [lpvr]) Lopinavir 1件: D01425 💬 - - 1件: 265 💬
78 L-carnitine Levocarnitine 3件: D02030, D02176, D04713 💬 - - 6件: 13, 96, 97, 265, 298, 316 💬
79 L-lactic acid L-Lactic acid 1件: D00111 💬 - - 1件: 265 💬
80 Lactic acid Lactic acid 1件: D00111 💬 - - 2件: 265, 299 💬
81 Lamivudine Lamivudine 1件: D00353 💬 - - 6件: 26, 42, 46, 135, 265, 325 💬
82 Lamivudine/zidovudine Lamivudine 2件: D00353, D00413 💬 - - 1件: 265 💬
83 Leptin Leptin - - - 2件:  6 , 265 💬
84 Lopinavir Lopinavir 1件: D01425 💬 - - 1件: 265 💬
85 Lopinavir/ritonavir Lopinavir 2件: D00427, D01425 💬 - - 1件: 265 💬
86 Lopinavir/ritonavir + nevirapine Lopinavir 3件: D00427, D00435, D01425 💬 - - 1件: 265 💬
87 Lopinavir/ritonavir + zidovudine + lamivudine Lamivudine 4件: D00353, D00413, D00427, D01425 💬 - - 1件: 265 💬
88 Low-dose regn4461 - - - - 1件: 265 💬
89 Mecasermin Mecasermin 2件: D03297, D04870 💬 2件: GHR, IGF1R 💬 33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway 5件: 78, 96, 168, 265, 299 💬
90 Metformin Metformin 2件: D00944, D04966 💬 2件: PRKAA1, PRKAA2 💬 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 21件:  2 ,  6 , 13, 46, 49, 60, 67, 75, 77, 81, 86, 113, 127, 158, 206, 225, 233, 265, 285, 299, 301 💬
91 Metformin hydrochloride Metformin 2件: D00944, D04966 💬 2件: PRKAA1, PRKAA2 💬 19件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 5件: 81, 158, 265, 299, 301 💬
92 Metreleptin Metreleptin 1件: D05014 💬 1件: LEPR 💬 6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 1件: 265 💬
93 Metrelpetin - - - - 1件: 265 💬
94 Monotherapy (lopinavir/ritonavir) Lopinavir 2件: D00427, D01425 💬 - - 1件: 265 💬
95 Monotherapy (lopinavir/ritonavir) + abc/3tc Lopinavir 2件: D00427, D01425 💬 - - 1件: 265 💬
96 Myalept - - - - 1件: 265 💬
97 Nelfinavir Nelfinavir 2件: D00899, D08259 💬 - - 3件: 49, 265, 331 💬
98 Nelfinavir mesylate Nelfinavir 2件: D00899, D08259 💬 - - 1件: 265 💬
99 Nevirapine Nevirapine 1件: D00435 💬 - - 1件: 265 💬
100 Niacin Niacin 1件: D00049 💬 - - 3件:  6 , 78, 265 💬
101 Non-nucleoside reverse transcriptase inhibitors - - - - 1件: 265 💬
102 Norvir - - - - 2件: 265, 299 💬
103 Nucleomaxx - - - - 1件: 265 💬
104 Nucleoside analogue sparing haart regimen - - - - 1件: 265 💬
105 Nucleoside reverse transcriptase inhibitors - - - - 1件: 265 💬
106 Obeticholic acid Obeticholic acid 1件: D09360 💬 1件: NR1H4 💬 1件: Bile secretion 3件: 93, 265, 296 💬
107 Other: glycerine gel Glycerin 1件: D00028 💬 - - 1件: 265 💬
108 Other: observation - - - - 1件: 265 💬
109 Perform blood cells and fibroblasts biochemical and immuno-labeled investigations - - - - 1件: 265 💬
110 Pioglitazone Pioglitazone 2件: D00945, D08378 💬 1件: PPARG 💬 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 17件:  2 ,  6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬
111 Pioglitazone or metformin Metformin 4件: D00944, D00945, D04966, D08378 💬 3件: PPARG, PRKAA1, PRKAA2 💬 25件: AMPK signaling pathway, Adipocytokine signaling pathway, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Huntington disease, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Osteoclast differentiation, Oxytocin signaling pathway, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Tight junction, Transcriptional misregulation in cancer, mTOR signaling pathway 1件: 265 💬
112 Pneumococcal polysaccharide vaccine 23 valent - - - - 1件: 265 💬
113 Poly-l-lactic acid L-Lactic acid 1件: D00111 💬 - - 1件: 265 💬
114 Pravastatin Pravastatin 2件: D00893, D08410 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬
115 Pravastatin sodium Pravastatin 2件: D00893, D08410 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 1件: 265 💬
116 Prevenar13 - - - - 2件: 19, 265 💬
117 Procedure: testosterone injection Testosterone 6件: D00075, D00957, D00958, D00959, D06085, D06087 💬 1件: AR 💬 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer 1件: 265 💬
118 Protease inhibitor - - - - 1件: 265 💬
119 Protease inhibitors - - - - 1件: 265 💬
120 R-methuleptin Metreleptin 1件: D05014 💬 1件: LEPR 💬 6件: AMPK signaling pathway, Adipocytokine signaling pathway, Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease 1件: 265 💬
121 Raltegravir Raltegravir 1件: D06676 💬 - - 4件: 13, 26, 93, 265 💬
122 Recombinant human growth hormone Somatotropin 1件: D02691 💬 1件: GHR 💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 3件: 78, 193, 265 💬
123 Recombinant human growth hormone + rosiglitazone Rosiglitazone 3件: D00596, D02691, D08491 💬 2件: GHR, PPARG 💬 14件: AMPK signaling pathway, Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Huntington disease, JAK-STAT signaling pathway, Longevity regulating pathway, Neuroactive ligand-receptor interaction, Osteoclast differentiation, PI3K-Akt signaling pathway, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 1件: 265 💬
124 Reyataz - - - - 1件: 265 💬
125 Reyataz 150mg 60 cps bl - - - - 1件: 265 💬
126 Riboflavin Riboflavin 3件: D00050, D01622, D01913 💬 - - 8件: 13, 38, 46, 96, 97, 162, 168, 265 💬
127 Ritonavir Ritonavir 1件: D00427 💬 - - 3件:  2 , 86, 265 💬
128 Ritonavir (norvir) Ritonavir 1件: D00427 💬 - - 1件: 265 💬
129 Rosiglitazone Rosiglitazone 2件: D00596, D08491 💬 1件: PPARG 💬 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 5件: 46, 75, 97, 222, 265 💬
130 Rosiglitazone maleate Rosiglitazone 2件: D00596, D08491 💬 1件: PPARG 💬 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 3件: 46, 75, 265 💬
131 Rtv - - - - 1件: 265 💬
132 Saquinavir Saquinavir 2件: D00429, D01160 💬 - - 2件: 86, 265 💬
133 Serostim®[somatropin (rdna origin) for injection] Somatotropin 1件: D02691 💬 1件: GHR 💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 1件: 265 💬
134 Setmelanotide Setmelanotide 1件: D11927 💬 1件: MC4R 💬 1件: Neuroactive ligand-receptor interaction 2件: 202, 265 💬
135 Simvastatin Simvastatin 1件: D00434 💬 1件: HMGCR 💬 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 21件:  6 , 13, 15, 34, 46, 49, 51, 66, 79, 86, 89, 94, 158, 160, 162, 195, 265, 288, 298, 299, 310 💬
136 Somatropin Somatotropin 1件: D02691 💬 1件: GHR 💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 16件:  2 ,  3 , 19, 46, 74, 75, 78, 96, 113, 187, 193, 195, 265, 274, 276, 299 💬
137 St200 - - - - 1件: 265 💬
138 Standard continuous antiretroviral therapy - - - - 1件: 265 💬
139 Stavudine Stavudine 1件: D00445 💬 - - 1件: 265 💬
140 Sulfate Sulfate ion - - - 25件:  2 ,  6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬
141 Sustiva - - - - 1件: 265 💬
142 Tat4 gel concentration a - - - - 1件: 265 💬
143 Tat4 gel concentration b - - - - 1件: 265 💬
144 Tenofovir Tenofovir 1件: D06074 💬 - - 5件:  2 , 25, 93, 265, 325 💬
145 Tenofovir df Tenofovir 1件: D06074 💬 - - 1件: 265 💬
146 Tenofovir disoproxil Tenofovir 2件: D01982, D06074 💬 - - 2件: 93, 265 💬
147 Tenofovir disoproxil fumarate Tenofovir 2件: D01982, D06074 💬 - - 1件: 265 💬
148 Tesamorelin Tesamorelin 2件: D06655, D09015 💬 1件: GHRHR 💬 2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 2件: 78, 265 💬
149 Tesamorelin (egrifta) Tesamorelin 2件: D06655, D09015 💬 1件: GHRHR 💬 2件: Growth hormone synthesis, secretion and action, Neuroactive ligand-receptor interaction 1件: 265 💬
150 Testosterone Testosterone 6件: D00075, D00957, D00958, D00959, D06085, D06087 💬 1件: AR 💬 3件: Oocyte meiosis, Pathways in cancer, Prostate cancer 8件:  1 ,  2 ,  3 , 13, 60, 78, 113, 265 💬
151 Th9507 - - - - 1件: 265 💬
152 Thiamine Thiamine 1件: D08580 💬 - - 3件:  8 , 13, 265 💬
153 Tipranavir Tipranavir 2件: D03843, D08605 💬 - - 1件: 265 💬
154 Total dietary replacement - - - - 1件: 265 💬
155 Truvada - - - - 1件: 265 💬
156 Use of lipid-lowering drugs. - - - - 1件: 265 💬
157 Viral load driven treatment interruption - - - - 1件: 265 💬
158 Volanesorsen Volanesorsen 1件: D11648 💬 1件: APOC3 💬 2件: Cholesterol metabolism, PPAR signaling pathway 1件: 265 💬
159 Volanesorsen sodium, apoc-iii antisense oligonucleotide Volanesorsen 1件: D11648 💬 1件: APOC3 💬 2件: Cholesterol metabolism, PPAR signaling pathway 1件: 265 💬
160 Zidovudine Zidovudine 1件: D00413 💬 - - 6件: 25, 26, 135, 265, 325, 331 💬

先頭へ